The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Estrogen Metabolism and Risk of Breast Cancer: A Prospective Study of the 2:16α-Hydroxyestrone Ratio in Premenopausal and Postmenopausal Women
Abstract
Experimental and clinical evidence suggests that 16alpha-hydroxylated estrogen metabolites, biologically strong estrogens, are associated with breast cancer risk, while 2-hydroxylated metabolites, with lower estrogenic activity, are weakly related to this disease. This study analyzes the association of breast cancer risk with estrogen metabolism, expressed as the ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone, in a prospective nested case-control study. Between 1987 and 1992, 10,786 women (ages 35-69 years) were recruited to a prospective study on breast cancer in Italy, the "Hormones and Diet in the Etiology of Breast Cancer" (ORDET) study. Women with a history of cancer and women on hormone therapy were excluded at baseline. At recruitment, overnight urine was collected from all participants and stored at -80 degrees C. After an average of 5.5 years of follow-up, 144 breast cancer cases and four matched controls for each case were identified among the participants of the cohort. Among premenopausal women, a higher ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone at baseline was associated with a reduced risk of breast cancer: women in the highest quintile of the ratio had an adjusted odds ratio (OR) for breast cancer of 0.58 [95% confidence interval (CI) = 0.25-1.34]. The corresponding adjusted OR in postmenopausal women was 1.29 (95% CI = 0.53-3.10). Results of this prospective study support the hypothesis that the estrogen metabolism pathway favoring 2-hydroxylation over 16alpha-hydroxylation is associated with a reduced risk of invasive breast cancer risk in premenopausal women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
The analysis of case-control studies
Breslow, N. E., & Day, N. E. (1980) · International Agency for Research on Cancer eBooks · Cited by 2,415
Statistical methods in cancer research. Vol. 1. The analysis of case-control studies
(1983) · Food and Chemical Toxicology · doi:10.1016/0278-6915(83)90281-8 · Cited by 1,716
Telang, N. T., Suto, A., Wong, G. Y., Osborne, M. P., & Bradlow, H. L. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.8.634 · Cited by 261
Self-citationAbnormal oxidative metabolism of estradiol in women with breast cancer.
Schneider, J., Kinne, D., Fracchia, A., Pierce, V, Anderson, K. E., Bradlow, H. L., & Fishman, J. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.9.3047 · Cited by 254
Self-citationCLARK, J. H., PASZKO, Z., & PECK, E. J. (1977) · Endocrinology · doi:10.1210/endo-100-1-91 · Cited by 243
FISHMAN, J., & MARTUCCI, C. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-3-611 · Cited by 215
Urinary estrogen metabolites and breast cancer: a case-control study.
Kabat, G. C., Chang, C., Sparano, J. A., Sepkovie, D. W., Hu, X. P., Khalil, A. I., Rosenblatt, R., & Bradlow, H. L. (1997) · PubMed · Cited by 211
Self-citationBradlow, H. L., Hershcopf, R. J., Martucci, C. P., & Fishman, J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.18.6295 · Cited by 204
Self-citationDo urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up
Meilahn, E., De Stavola, B., Allen, D., Fentiman, I., Bradlow, H., Sepkovic, D., & Kuller, L. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.663 · Cited by 168
Self-citation
Cited by
Plottel, C. S., & Blaser, M. J. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.10.003 · Cited by 743
The Intestinal Microbiome and Estrogen Receptor–Positive Female Breast Cancer
(2016) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw029 · Cited by 523
Gut Bacterial Metabolism of the Soy Isoflavone Daidzein: Exploring the Relevance to Human Health
Atkinson, C., Frankenfeld, C. L., & Lampe, J. W. (2005) · Experimental Biology and Medicine · doi:10.1177/153537020523000302 · Cited by 515
Brown, E. M., Allsopp, P. J., Magee, P. J., Gill, C. I., Nitecki, S., Strain, C. R., & McSorley, E. M. (2014) · Nutrition Reviews · doi:10.1111/nure.12091 · Cited by 392
Estrogen metabolism and breast cancer
Samavat, H., & Kurzer, M. S. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.04.018 · Cited by 380
Metadata
- Authors
- Muti, P., Bradlow, H. L., Micheli, A., Krogh, V., Freudenheim, J. L., Schünemann, H. J., Stanulla, M., Yang, J., Sepkovic, D. W., Trevisan, M., & Berrino, F.
- Venue
- Epidemiology
- Published
- 2000-11
- Volume
- 11
- Issue
- 6
- Pages
- 635-640
- ISSN
- 1044-3983 (ISSN-L)
- OpenAlex
- W1971545670
- Cited by
- 266
- References
- 23
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estrogen Metabolism and Risk of Breast Cancer: A Prospective Study of the 2:16α-Hydroxyestrone Ratio in Premenopausal and Postmenopausal Women. https://app.cochat.ai/papers/10.1097/00001648-200011000-00004
- The paper
- Muti, P., Bradlow, H. L., Micheli, A., Krogh, V., Freudenheim, J. L., Schünemann, H. J., Stanulla, M., Yang, J., Sepkovic, D. W., Trevisan, M., & Berrino, F. (2000). Estrogen Metabolism and Risk of Breast Cancer: A Prospective Study of the 2:16α-Hydroxyestrone Ratio in Premenopausal and Postmenopausal Women. Epidemiology. https://doi.org/10.1097/00001648-200011000-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.